Vifor Pharma (GNHAF) Short Interest Ratio & Short Volume

Short interest is the volume of Vifor Pharma shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 300 shares of GNHAF short. Learn More on Vifor Pharma's current short interest.

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.48 billion), Charter Communications, Inc. ($2.85 billion), Twitter, Inc. ($1.89 billion), T. Rowe Price Group, Inc. ($1.78 billion), Coinbase Global, Inc. ($1.77 billion), PG&E Co. ($1.75 billion), Lucid Group, Inc. ($1.58 billion), Rivian Automotive, Inc. ($1.42 billion), Roblox Co. ($1.39 billion), and Williams-Sonoma, Inc. ($1.33 billion). View all of the most shorted stocks.

Short selling GNHAF is an investing strategy that aims to generate trading profit from Vifor Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Vifor Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNHAF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNHAF, twice per month. The most recent reporting period available is October, 15 2022.